A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in China https://www.medrxiv.org/content/10.1101/2023.02.28.23286535
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.